Solène Thorey, Augustin Behaghel, Jordan Sibeoni, Corinne Blanchet, Marie Rose Moro, Emilie Carretier, Maude Ludot-Grégoire
{"title":"Lived experiences of adolescents with anorexia nervosa and their parents during olanzapine treatment: a qualitative study.","authors":"Solène Thorey, Augustin Behaghel, Jordan Sibeoni, Corinne Blanchet, Marie Rose Moro, Emilie Carretier, Maude Ludot-Grégoire","doi":"10.1186/s40337-025-01327-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Olanzapine is commonly prescribed in Anorexia Nervosa, despite conflicting evidence regarding its efficacy and safety. This study aimed to complement existent quantitative by exploring the lived experiences of adolescents and parents with this treatment.</p><p><strong>Method: </strong>Ten adolescent girls and ten parents were interviewed in a single psychiatric department in Paris. Data saturation was achieved. We used semi-structured interviews enriched with narrative methods, including writing tasks and picture elicitation questions.</p><p><strong>Results: </strong>Four chronological meta-themes were identified: (1) Introduction of antipsychotic treatment with Olanzapine: rapid acceptance generating mixed feelings about the future. (2) The first few weeks of medication: Adolescents questioning alone the treatment after first intakes. (3) Taking note of the results during the initial few months of treatment. (4) Then what? Fears and doubts about the future.</p><p><strong>Conclusion: </strong>The prescription of olanzapine was often perceived as a liminal stage-a transitional moment akin to a \"rite of passage\" in the trajectory of Anorexia Nervosa. For many adolescents, it represented an opportunity to assert autonomy and gain a sense of empowerment in their relationships with both the medical team and their parents. However, implicit concerns about weight gain as a side effect often became a core issue of miscommunication. These concerns should be openly addressed throughout the treatment process. Shortening the usual duration of olanzapine therapy may offer a constructive path toward reinforcing the therapeutic alliance and avoiding non-medical discontinuation.</p>","PeriodicalId":48605,"journal":{"name":"Journal of Eating Disorders","volume":"13 1","pages":"146"},"PeriodicalIF":4.5000,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12281770/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Eating Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40337-025-01327-6","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Olanzapine is commonly prescribed in Anorexia Nervosa, despite conflicting evidence regarding its efficacy and safety. This study aimed to complement existent quantitative by exploring the lived experiences of adolescents and parents with this treatment.
Method: Ten adolescent girls and ten parents were interviewed in a single psychiatric department in Paris. Data saturation was achieved. We used semi-structured interviews enriched with narrative methods, including writing tasks and picture elicitation questions.
Results: Four chronological meta-themes were identified: (1) Introduction of antipsychotic treatment with Olanzapine: rapid acceptance generating mixed feelings about the future. (2) The first few weeks of medication: Adolescents questioning alone the treatment after first intakes. (3) Taking note of the results during the initial few months of treatment. (4) Then what? Fears and doubts about the future.
Conclusion: The prescription of olanzapine was often perceived as a liminal stage-a transitional moment akin to a "rite of passage" in the trajectory of Anorexia Nervosa. For many adolescents, it represented an opportunity to assert autonomy and gain a sense of empowerment in their relationships with both the medical team and their parents. However, implicit concerns about weight gain as a side effect often became a core issue of miscommunication. These concerns should be openly addressed throughout the treatment process. Shortening the usual duration of olanzapine therapy may offer a constructive path toward reinforcing the therapeutic alliance and avoiding non-medical discontinuation.
期刊介绍:
Journal of Eating Disorders is the first open access, peer-reviewed journal publishing leading research in the science and clinical practice of eating disorders. It disseminates research that provides answers to the important issues and key challenges in the field of eating disorders and to facilitate translation of evidence into practice.
The journal publishes research on all aspects of eating disorders namely their epidemiology, nature, determinants, neurobiology, prevention, treatment and outcomes. The scope includes, but is not limited to anorexia nervosa, bulimia nervosa, binge eating disorder and other eating disorders. Related areas such as important co-morbidities, obesity, body image, appetite, food and eating are also included. Articles about research methodology and assessment are welcomed where they advance the field of eating disorders.